A Kaiser Permanante study surveyed bladder cancer patients and found that current and former smokers were aware of a connection between smoking and their disease.
More than half of bladder cancers in the U.S. are the result of smoking, and 90% of smokers with the disease are aware of the connection, according to a new study.
" is actually the second most common smoking-related cancer, second only to lung," said lead author Dr. Jeffrey C. Bassett of Kaiser Permanente Southern California in Anaheim.
Although previous studies had suggested that few people understood the connection between bladder cancer and tobacco, this new study found the opposite, he said.
"Bladder cancer patients smoking at diagnosis appear to accept that their own smoking caused their cancer, positioning them for a more motivated (and more likely successful) attempt at quitting," Bassett said.
He and his team surveyed 1,198 men and women who had been diagnosed with bladder cancer between 2006 and 2009 in the California Cancer Registry about their smoking history, and 790 completed the survey.
Read the complete article on Medscape: http://bit.ly/1tNny6u
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
FDA Approves Tislelizumab for Advanced or Metastatic ESCC After Chemotherapy
March 15th 2024The FDA has approved tislelizumab-jsgr (Tevimbra) for single-agent use in adult patients with unresectable or metastatic esophageal squamous cell carcinoma following prior systemic chemotherapy that did not include a PD-1/PD-L1 inhibitor.
Read More